尿LAM与尿Xpert MTB/RIF Ultra在HIV住院成人中诊断结核的性能比较
以微生物学结核为参考,尿Ultra灵敏度70%显著高于尿LF-LAM的45%,两者特异度分别为100%和93%,无显著差异。尿Ultra联合LF-LAM对微生物学结核的诊断产出为73%。
要点
- 尿Ultra灵敏度70%,显著高于尿LF-LAM的45%(McNemar P=.0013)。
- 尿Ultra特异度100%,尿LF-LAM特异度93%,两者差异无统计学意义(P=.25)。
- 尿Ultra联合LF-LAM的诊断产出为73%,可识别近四分之三的HIV住院结核患者。
核心结论
- 尿Ultra联合LF-LAM可识别近四分之三的HIV住院成人中微生物学结核。
- 尿Ultra灵敏度较LF-LAM显著提高。
研究设计与样本
- 入组标准为≥1项W4SS或临床怀疑结核,血、痰、尿行结核培养。
- 未处理尿行LF-LAM检测,15 mL离心尿沉渣行Ultra检测。
- 主要结局为尿Ultra与LF-LAM的灵敏度比较,以微生物学结核(结核培养或分子检测阳性,排除尿Ultra)为参考。
主要发现
- 以微生物学结核为参考,尿LF-LAM灵敏度45%(95%CI 32-58),尿Ultra灵敏度70%(95%CI 57-81;McNemar P=.0013)。
- 尿LF-LAM特异度93%(95%CI 81-99),尿Ultra特异度100%(95%CI 92-100;McNemar P=.25)。
- 微生物学结核诊断产出:痰Ultra 34%,尿LF-LAM 45%,尿Ultra 68%,尿LF-LAM联合尿Ultra 73%。
关键数值与推荐
- 尿LF-LAM灵敏度45%(95%CI 32-58),尿Ultra灵敏度70%(95%CI 57-81),McNemar P=.0013。
- 尿LF-LAM特异度93%(95%CI 81-99),尿Ultra特异度100%(95%CI 92-100),McNemar P=.25。
- 诊断产出:痰Ultra 34%,尿LF-LAM 45%,尿Ultra 68%,尿LF-LAM联合尿Ultra 73%。
临床怎么用
- 对HIV住院成人怀疑结核时,可考虑尿Ultra联合尿LF-LAM检测以提高诊断产出。
- 尿Ultra较LF-LAM灵敏度更高,联合检测可识别近四分之三的微生物学结核。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Urine lateral flow lipoarabinomannan (LF-LAM) is a point-of-care tuberculosis (TB) test for patients with human immunodeficiency virus (HIV). Xpert MTB/RIF Ultra (Ultra) has improved sensitivity on sputum compared with the previous generation of Xpert and may improve diagnostic yield for TB on urine-based testing. METHODS: We conducted a diagnostic accuracy study in East London, South Africa. Adults with HIV hospitalized with ≥1 W4SS (World Health Organization-recommended 4-symptom screen) or clinical concern for TB were enrolled; TB cultures were performed on blood, sputum, and urine. Unprocessed urine was tested with LF-LAM and Ultra on the pellet of 15 mL centrifuged urine. The primary outcome was sensitivity of urine Ultra compared with LF-LAM, with microbiological TB (positive TB culture or molecular test, excluding urine Ultra) as the reference. Secondary outcomes included specificity and diagnostic yield. RESULTS: Two hundred thirty-eight participants were enrolled with a median CD4 count of 76 cells/mm3. Microbiological TB was diagnosed in 62 (26%). Using microbiological TB as the reference, sensitivity of LF-LAM and urine Ultra was 45% (95% confidence interval, 32-58) and 70% (95% CI, 57-81; McNemar P = .0013); specificity was 93% (95% CI, 81-99) and 100% (95% CI, 92-100; McNemar P = .25). Diagnostic yields for microbiological TB were 34% for sputum Ultra, 45% for urine LF-LAM, 68 for urine Ultra, and 73% for urine LF-LAM and urine Ultra combined. CONCLUSIONS: Combined urine-based testing (Ultra + LF-LAM) identified nearly three-quarters of medical inpatients with HIV with microbiological TB. Urine Ultra had significantly improved sensitivity compared with LF-LAM.
引用
- Stead D, Wasserman S, Steenkamp E, et al. Comparative Performance of Urine Lipoarabinomannan and Urine Xpert MTB/RIF Ultra for Diagnosing Tuberculosis in Adult Inpatients With HIV in East London, South Africa. Clin Infect Dis. 2025. PMID: 40172283. doi:10.1093/cid/ciaf080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。